TREX1 overexpression is observed in oesophageal [212] and cervical [213] cancers but is downregulated in melanoma [214] and osteosarcoma [215], where TREX1 expression is only observed in non-metastatic patients. This evidence concerns the gene TREX1 and osteosarcoma.